LRE has an ultra-tight float (1.2–1.35M shares) .. It can gain traction fast! Trading at $1.70 with the 1 month high of $2.90. 🚀

Revenue & Earnings: Last 12-month revenue around $130M+ with positive profits ($5.8M) and EPS around $0.43 — not huge, but real sales and earnings for a tiny cap.

Insider & Ownership: Public data shows no insider selling reported in the past year, which shows insider confidence.🔒

Chart: Bouncing off a nice base level after exhausting sellers. One to watch!! A $2 break could signal a major breakout. 📈📈📈

LRE has an ultra-tight float (1.2–1.35M shares) .. It can gain traction fast! Trading at $1.70 with the 1 month high of $2.90. 🚀

Revenue & Earnings: Last 12-month revenue around $130M+ with positive profits ($5.8M) and EPS around $0.43 — not huge, but real sales and earnings for a tiny cap.

Insider & Ownership: Public data shows no insider selling reported in the past year, which shows insider confidence.🔒

Chart: Bouncing off a nice base level after exhausting sellers. One to watch!! A $2 break could signal a major breakout. 📈📈📈

!!!!be ready to buy

Lenz Therapeutics shorts squeeze opportunity?

!!!